Clinical Outcomes with Pemetrexed-Based Systemic Therapy in RET-Rearranged Lung Cancers

被引：0
|
作者：
Drilon, Alexander [1 ]
Bergagnini, Isabella [1 ]
Delasos, Lukas [1 ]
Sima, Camelia S. [1 ]
Smith, Roger [1 ]
Somwar, Romel [1 ]
Riely, Gregory J. [1 ]
Kris, Mark G. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
ROS1 ALK KRAS; RET; pemetrexed; rearrangement;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ORAL03.05
引用
收藏
页码：S178 / S178
页数：1
相关论文
共 50 条
  • [21] RET-Rearranged Lung Adenocarcinoma with Paraneoplastic Meige Syndrome
    Abbar, Baptiste
    Henry, Carole
    Theou-Anton, Nathalie
    Brosseau, Solenn
    Nguenang, Marina
    Pluvy, Johan
    Assoun, Sandra
    Zalcman, Gerard
    Gounant, Valerie
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : E250 - E251
  • [22] Real World Treatment Outcomes in Chinese Patients with RET-Rearranged Lung Cancer
    Yang, L.
    Liu, Z.
    Qiu, W.
    Yang, G.
    Xu, H.
    Wang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S829 - S829
  • [23] Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients
    Zhang, Kai
    Chen, Huajun
    Wang, Ye
    Yang, Lin
    Zhou, Chengzhi
    Yin, Weiqiang
    Wang, Guangsuo
    Mao, Xinru
    Xiang, Jianxing
    Li, Bing
    Zhang, Tengfei
    Fei, Shihong
    ONCOLOGY RESEARCH, 2019, 27 (05) : 575 - 582
  • [24] Clinical Characteristics and Molecular Patterns Of RET-Rearranged Lung Cancer in Chinese Patients
    Fei, S.
    Zhang, K.
    Chen, H.
    Wang, Y.
    Yang, L.
    Zhou, C.
    Yin, W.
    Wang, G.
    Li, B.
    Zhang, T.
    Xiang, J.
    Mao, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1077 - S1077
  • [25] Clinical development of RET inhibitors in RET-rearranged non-small cell lung cancer: Update
    Mendoza, Luis
    ONCOLOGY REVIEWS, 2018, 12 (02) : 69 - 73
  • [26] Identification of Mechanisms of Drug Resistance in RET-Rearranged Lung Cancer
    Nakaoku, T.
    Kohno, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2276 - S2276
  • [27] Targeted Therapy For RET-Rearranged Non-Small Cell Lung Cancer: Clinical Development And Future Directions
    Ackermann, Christoph Jakob
    Stock, Gustavo
    Tay, Rebecca
    Dawod, Mohammed
    Gomes, Fabio
    Califano, Raffaele
    ONCOTARGETS AND THERAPY, 2019, 12 : 7857 - 7864
  • [28] Identification of mechanisms of drug resistance in RET-rearranged lung cancer
    Nakaoku, Takashi
    Kohno, Takashi
    CANCER SCIENCE, 2018, 109 : 740 - 740
  • [29] The importance of RET-directed therapy in patients with RET-rearranged non-small cell lung cancer
    Yoh, Kiyotaka
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S121 - S123
  • [30] RET-Rearranged Lung Adenocarcinomas with Lymphangitic Spread, Psammoma Bodies, and Clinical Responses to Cabozantinib
    Mukhopadhyay, Sanjay
    Pennell, Nathan A.
    Ali, Siraj M.
    Ross, Jeffrey S.
    Ma, Patrick C.
    Velcheti, Vamsidhar
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (11) : 1714 - 1719
12345